View Older Stories

Feb 19, 2026 08:00AM Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial

Feb 17, 2026 08:00AM Envoy Medical Nears Completion of Enrollment in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant

Feb 12, 2026 04:07PM Envoy Medical closes $78 million public offering with milestone warrants

Feb 12, 2026 04:05PM Envoy Medical Announces Closing of Up to $78.0 Million Upsized Public Offering

Feb 11, 2026 09:27AM Envoy Medical prices $78 million public offering with milestone warrants

Feb 11, 2026 09:25AM Envoy Medical Announces Pricing of Up to $78.0 Million Upsized Public Offering

Dec 18, 2025 08:05AM Envoy Medical reaches midpoint enrollment in cochlear implant study

Dec 18, 2025 08:00AM Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant

Dec 16, 2025 08:02AM Envoy Medical receives Australian patent for cochlear implant technology

Dec 16, 2025 08:00AM Envoy Medical Secures New Australian Patent for Cochlear Implant Innovation Aimed at Enhancing Input Signal-to-Noise Ratio

Dec 10, 2025 08:00AM Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear Implant

Dec 4, 2025 08:00AM Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient

Dec 2, 2025 08:00AM Envoy Medical Announces the Grant of Its 40th U.S. Patent

Dec 1, 2025 04:34PM Envoy Medical (COCH) filed for 15.12M share offering by selling stockholders

Nov 20, 2025 08:00AM Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted Battery

Nov 18, 2025 08:00AM Envoy Medical Achieves Six-Month Milestone with First 10 Patients in Acclaim(R) Cochlear Implant Clinical Trial

Nov 10, 2025 08:00AM Envoy Medical Reports Third Quarter 2025 Financial and Operational Results

Nov 4, 2025 08:00AM Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial

Oct 29, 2025 08:00AM Envoy Medical Marks Three-Year Anniversary of First Patient Receiving Its Breakthrough Fully Implanted Cochlear Implant

Oct 27, 2025 08:04AM Envoy Medical receives Nasdaq listing extension until February 2026

Oct 27, 2025 08:00AM Envoy Medical Receives Positive Listing Determination from NASDAQ

Oct 17, 2025 11:03AM Envoy Medical (COCH) files for 15.12M share offering by selling stockholders

Oct 9, 2025 04:07PM Envoy Medical closes $16 million registered direct offering

Oct 9, 2025 04:05PM Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Oct 8, 2025 07:02AM Envoy Medical raises $4 million in registered direct offering

Oct 8, 2025 07:00AM Biotech and Medical Tech Stocks Report Breakthrough Clinical Trial Updates

Oct 8, 2025 07:00AM Envoy Medical Announces up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Oct 7, 2025 08:02AM Envoy Medical gets FDA approval to advance cochlear implant trial

Oct 7, 2025 08:00AM Envoy Medical Receives FDA Approval to Advance Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data

Oct 1, 2025 08:00AM Envoy Medical to Participate in the American Academy of Otolaryngology Head and Neck Surgery (AAO-HNSF) Conference on October 11th-14th

Sep 25, 2025 08:02AM Envoy Medical closes $2.5M stock offering at $1.31 per share

Sep 25, 2025 08:00AM Envoy Medical Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Sep 24, 2025 08:00AM Envoy Medical Advances Commercialization Planning for Breakthrough Hearing Device as FDA Clinical Trial Remains On Track

Sep 22, 2025 08:02AM Envoy Medical raises $2.5 million in registered direct offering

Sep 22, 2025 08:00AM Envoy Medical Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Sep 19, 2025 08:00AM Envoy Medical Expands Patent Portfolio by Securing Additional European Patent for Breakthrough Cochlear Implant Technology

Sep 10, 2025 08:03AM Envoy Medical eliminates $32 million debt, advances clinical trial

Sep 10, 2025 08:00AM Envoy Medical Issues Letter to Shareholders and Provides Update on Recent Accomplishments

Sep 9, 2025 08:00AM Envoy Medical Secures Four New Global Patents, Expanding Its Leadership Position in Fully Implantable Hearing Technology

Sep 8, 2025 08:00AM Envoy Medical to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8-10, 2025

Sep 3, 2025 08:00AM Envoy Medical Successfully Reaches Three-Month Follow-Up Milestone in Clinical Trial of the Acclaim Fully Implanted Cochlear Implant

Aug 26, 2025 08:00AM Envoy Medical Extinguishes over $32 Million in Debt, Strengthening Balance Sheet; Announces Retirement of Glen A. Taylor from Board

Aug 20, 2025 08:00AM Envoy Medical Secures Three New Patents, Strengthening Leadership in Fully Implantable Hearing Technology

Jul 31, 2025 08:00AM Envoy Medical Reports on Second Quarter 2025 Results

Jul 8, 2025 08:05AM Envoy Medical receives two new US patents for cochlear implant technology

Jul 8, 2025 08:00AM Envoy Medical Expands Patent Portfolio with New Issuances in the United States

Jul 1, 2025 08:00AM Envoy Medical Expands Global Patent Portfolio with New Issuances in Australia

Jun 26, 2025 08:00AM New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Go into Effect July 1, Unlocking New Opportunities for Envoy Medical

Jun 10, 2025 08:30AM Envoy Medical's Pivotal Clinical Trial for Fully Implanted Acclaim(R) Cochlear Implant Remains On Track After First Month Follow-Up

May 13, 2025 09:18AM Envoy Medical (COCH) Achieves Clinical Trial Milestone and is Optimistic About Expansion into Final Stage of Trial

View Older Stories